{"id":81692,"date":"2026-06-11T12:05:25","date_gmt":"2026-06-11T12:05:25","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/"},"modified":"2026-06-11T12:05:25","modified_gmt":"2026-06-11T12:05:25","slug":"60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/","title":{"rendered":"60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement"},"content":{"rendered":"<div>\n<ul type=\"disc\">\n<li><strong>License allows the Company to commence large-scale extraction of castanospermine from the seeds of\u00a0<\/strong><strong><em>Castanospermum australe<\/em><\/strong> <\/li>\n<li><strong>Company will meet with FDA on July 1, 2026, to discuss Non-Notified Letter issued by the Agency in response to the Company\u2019s recent New Dietary Ingredient Notification (NDIN) to market Australian Chestnut Extract in the U.S.<br \/><\/strong><u><br \/><\/u><\/li>\n<\/ul>\n<p>WASHINGTON, June  11, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7HPu3tzSaKK5hbhXguUDBCuSLxVeSZ2ptMkDkakqd5_JRtOHEzRK9HdWy0W6m9va_VpnQ4DS1CAY7i1ngGyQWcLqWlXc5jovLGOnxGzmmOHhvFOMz6aCT872GBmqTdUaemtg8hyihkx7h9re3g3rug==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>60 Degrees Pharmaceuticals, Inc.<\/u><\/a>\u00a0(NASDAQ: SXTP; SXTPW) (the \u201cCompany\u201d or \u201c60\u00a0Degrees Pharma\u201d), a pharmaceutical company focused on developing new medicines for vector-borne disease, announced that the Company has executed a patent licensing agreement with Florida State University to commence large-scale production techniques to extract and purify castanospermine from the seeds of\u00a0<em>Castanospermum australe<\/em> (commonly known as the Australian Chestnut, the Moreton Bay Chestnut, and the Black Bean Tree) for non-prescription uses. Castanospermine is the principal component of Australian Chestnut Extract.<\/p>\n<p>According to recent scientific literature, at low doses, castanospermine modulates carbohydrate metabolism, altering glycogen, glucose levels and other clinical markers. In animal models, high doses have been shown to impact disease outcomes in several therapeutic areas through immunomodulation.<\/p>\n<p>The U.S. Food and Drug Administration (FDA or \u201cthe Agency\u201d) has issued a\u00a0Non-Notification Letter\u00a0to 60 Degrees Pharma providing feedback on the Company\u2019s recent filing of a New Dietary Ingredient Notification (NDIN) for Australian Chestnut Extract.\u00a060 Degrees Pharma and the Agency will meet on July 1, 2026, to discuss the feedback, including clarification regarding the minimum required \u201cother safety information\u201d to establish the safety of the proposed use of Australian Chestnut Extract in a dietary supplement. Subsequently, the Company will submit a revised NDIN.<\/p>\n<p><em>Castanospermum australe<\/em>\u00a0grows primarily in the Australian states of Queensland and New South Wales, and in Florida, Hawaii, and California. The processed seeds of\u00a0<em>Castanospermum australe\u00a0<\/em>have been a traditional food source in Australia for thousands of years.<\/p>\n<p><strong>About\u00a060 Degrees Pharmaceuticals, Inc.<\/strong><br \/>60 Degrees Pharmaceuticals, Inc., founded in 2010, specializes in developing and commercializing new medicines for the treatment and prevention of vector-borne disease. The Company achieved\u00a0U.S. Food and Drug Administration\u00a0approval of its lead product, ARAKODA\u00ae (<strong>tafenoquine<\/strong>), for malaria prevention in 2018. ARAKODA is commercially available in the\u00a0U.S.\u00a0and\u00a0Australia.\u00a060 Degrees Pharmaceuticals, Inc.\u00a0also collaborates with prominent research and academic organizations in the\u00a0U.S.\u00a0and\u00a0Australia.\u00a060 Degrees Pharmaceuticals, Inc.\u00a0is headquartered in\u00a0Washington, D.C., with a subsidiary in\u00a0Australia. Learn more at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4UYz-u8rmW_aM_VQZU5Lo8e3V3snnB3MDIhDPkLVtd2D1iOjD-rbrYQinX1_7vQ4iLQ5Wi8SmfIFSw37cQn3OIA9pi2GzsHleNdfv7BQMKReoFmQ6hTny4OrlnglN5GK\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>www.60degreespharma.com<\/u><\/a>.<\/p>\n<p>The statements contained herein may include prospects, statements of future expectations and other forward-looking statements that are based on management\u2019s current views and assumptions and involve known and unknown risks and uncertainties. Actual results, performance or events may differ materially from those expressed or implied in such forward-looking statements.<\/p>\n<p><strong>Cautionary Note Regarding Forward-Looking Statements<\/strong><br \/>This press release may contain \u201cforward-looking statements\u201d within the meaning of the safe harbor provisions of the\u00a0U.S.\u00a0Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect the current view about future events. When used in this press release, the words \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cfuture,\u201d \u201cintend,\u201d \u201cplan,\u201d or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs,\u00a0expectations\u00a0and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, activities of regulators and future regulations and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: there is substantial doubt as to our ability to continue on a going-concern basis; we might not be eligible for Australian government research and development tax rebates; if we are not able to successfully develop, obtain FDA approval for, and provide for the commercialization of non-malaria prevention indications for\u00a0<strong>tafenoquine<\/strong>\u00a0(ARAKODA<sup>\u00ae<\/sup>\u00a0or other regimen) or Australian Chestnut Extract in a timely manner, we may not be able to expand our business operations; we may not be able to successfully conduct planned clinical trials or patient recruitment in our trials might be slow or negligible; and we have no manufacturing capacity which puts us at risk of lengthy and costly delays of bringing our products to market.\u00a0More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company\u2019s filings with the\u00a0Securities and Exchange Commission\u00a0(\u201cSEC\u201d), including the information contained in our Annual Report on Form 10-K filed with the\u00a0SEC\u00a0on\u00a0March 30, 2026, and our subsequent\u00a0SEC\u00a0filings. Investors and security holders are urged to read these documents free of charge on the SEC\u2019s website at\u00a0www.sec.gov. As a result of these matters, changes in facts, assumptions not being realized or other circumstances, the Company\u2019s actual results may differ materially from the expected results discussed in the forward-looking statements contained in this press release. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.<\/p>\n<p>Media Contact<br \/>Sheila A. Burke<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vzEzCZd5jxpxCqewpBy3gMBRsmr9JPNhASPLjk0TE0CtWb35_LrcP18BIq_EQTyQs5SmpibJTepzcF9izikekjInTHuvkSbODdhb0knUf_lpRQgWQ6mj7toM_EUuviozY9PbiIbKPOabvdpHvi6orrNCtOaOIMjAFs4V09wz2QoA2nkto9wbEXke8CE6y80N-mIZycqSl74PYVB8OaVYcygiNJvnMK4HOwtpi9c7n6qENRG63FmKTb7bG2Bqde6_GDLVoyXdPxQdg179ydUCAsdcDzyw4bIrVRPIgPhc0gAQMvhO50DI2z_xrJSUoQ2nqdoKTEhNXnz-n5c14Gs7QQnV_42cpF_ra2qLBO23SOtHWcExqjSFsUagcCtl9MRi\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>SheilaBurke-consultant@60degreespharma.com<\/u><\/a>\u00a0<br \/>(484) 667-6330\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>Investor Contact<br \/>Patrick Gaynes<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KBSGxty2G_KygodnH4NvyK2VJX_3W7Hfom58VPr9uhV0fXO-D_gm6YJ8Up9clk05UQV3XhNJ4VR4f_18ZUKfKpKRMvuVD8A-mxbG1S26V2TD-0GHBYB57V-YFZIH6UqYaDJUtEkvNHhIpueR3tCs-A==\" rel=\"nofollow\" target=\"_blank\" title=\"patrickgaynes@60degreespharma.com\">patrickgaynes@60degreespharma.com<\/a>\u00a0<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmI4ODEwYjYtNWY1YS00NGY0LTk5MjEtN2RjZWUzZWRkYjE1LTExOTM5MDctMjAyNi0wNi0xMS1lbg==\/tiny\/Sixty-Degrees-Pharmaceuticals.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>License allows the Company to commence large-scale extraction of castanospermine from the seeds of\u00a0Castanospermum australe Company will meet with FDA on July 1, 2026, to discuss Non-Notified Letter issued by the Agency in response to the Company\u2019s recent New Dietary Ingredient Notification (NDIN) to market Australian Chestnut Extract in the U.S. WASHINGTON, June 11, 2026 [&#8230;]\n","protected":false},"author":1,"featured_media":85254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-81692","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-people"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement\" \/>\n<meta property=\"og:description\" content=\"License allows the Company to commence large-scale extraction of castanospermine from the seeds of\u00a0Castanospermum australe Company will meet with FDA\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-11T12:05:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/05\/SaigonBiz-Feature-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1074\" \/>\n\t<meta property=\"og:image:height\" content=\"716\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement\",\"datePublished\":\"2026-06-11T12:05:25+00:00\",\"dateModified\":\"2026-06-11T12:05:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/\"},\"wordCount\":977,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"People\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/\",\"name\":\"60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-06-11T12:05:25+00:00\",\"dateModified\":\"2026-06-11T12:05:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/","og_locale":"en_US","og_type":"article","og_title":"60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement","og_description":"License allows the Company to commence large-scale extraction of castanospermine from the seeds of\u00a0Castanospermum australe Company will meet with FDA","og_url":"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-06-11T12:05:25+00:00","og_image":[{"width":1074,"height":716,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/05\/SaigonBiz-Feature-Image.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement","datePublished":"2026-06-11T12:05:25+00:00","dateModified":"2026-06-11T12:05:25+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/"},"wordCount":977,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["People"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/","url":"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/","name":"60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-06-11T12:05:25+00:00","dateModified":"2026-06-11T12:05:25+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/60-degrees-pharmaceuticals-signs-exclusive-patent-license-agreement-with-florida-state-university-for-non-prescription-use-of-australian-chestnut-extract-as-a-botanical-supplement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/81692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=81692"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/81692\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/85254"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=81692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=81692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=81692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}